Challenges in Realizing Selectivity for Nanoparticle Biodistribution and clearance: Lessons From Gold Nanoparticles

References

• Duncan R . Nanomedicine gets clinical. Materials Today8 (8 Suppl.), 16–17 (2005).
   Web of Science ®Google Scholar
• Weissig V Pettinger TK Murdock N . Nanopharmaceuticals (part 1): products on the market. Int. J. Nanomed.9, 4357–4373 (2014).
   PubMed Web of Science ®Google Scholar
• Ragelle H Danhier F Préat V Langer R Anderson DG . Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin. Drug Deliv.1–14 (2016).
   Web of Science ®Google Scholar
• Adams DH Eksteen B . Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat. Rev. Immunol.6 (3), 244–251 (2006).
   PubMed Web of Science ®Google Scholar
• Stylianopoulos T Jain RK . Design considerations for nanotherapeutics in oncology. Nanomedicine11 (8), 1893–1907 (2015).
   PubMed Web of Science ®Google Scholar
• Romano EL Romano M . Staphylococcal protein a bound to colloidal gold: a useful reagent to label antigen-antibody sites in electron microscopy. Immunochemistry14 (9), 711–715 (1977).
   Google Scholar
• Albanese A Tsoi KM Chan WCW . Simultaneous quantification of cells and nanomaterials by inductive-coupled plasma techniques. J. Lab. Autom.18 (1), 99–104 (2013).
   PubMedGoogle Scholar
• Matsumura Y Maeda H . A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res.46 (12 Part 1), 6387–6392 (1986).
   PubMed Web of Science ®Google Scholar
• Maeda H . Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Control. Rel.164 (2), 138–144 (2012).
   PubMed Web of Science ®Google Scholar
• Clark AJ Wiley DT Zuckerman JE et al. CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing. Proc. Natl Acad. Sci. USA113 (14), 3850–3854 (2016).
   PubMed Web of Science ®Google Scholar
• Prabhakar U Maeda H Jain RK et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res.73 (8), 2412–2417 (2013).
   PubMed Web of Science ®Google Scholar
• Longmire M Choyke PL Kobayashi H . Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond.)3 (5), 703–717 (2008).
   PubMed Web of Science ®Google Scholar
• Tsoi KM Macparland SA Ma X-Z et al. Mechanism of hard-nanomaterial clearance by the liver. Nat. Mater.15 (11), 1212–1221 (2016).
   PubMed Web of Science ®Google Scholar
• Semmler-Behnke M Kreyling WG Lipka J et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small4 (12), 2108–2111 (2008).
   PubMed Web of Science ®Google Scholar
• Haschek WM Rousseaux CG Wallig MA . Chapter 9–The liver. In : Fundamentals of Toxicologic Pathology (2nd Edition). Academic Press, San Diego, CA, USA, 197–235 (2010).
   Google Scholar
• Zhang Y-N Poon W Tavares AJ Mcgilvray ID Chan WCW . Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J. Control. Rel.240, 332–348 (2016).
   PubMed Web of Science ®Google Scholar
• Braet F Wisse E . Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp. Hepatol.1, 1–1 (2002).
   PubMedGoogle Scholar
• Cho W-S Cho M Jeong J et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol.236 (1), 16–24 (2009).
   PubMed Web of Science ®Google Scholar
• Cho W-S Cho M Jeong J et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol.245 (1), 116–123 (2010).
   PubMed Web of Science ®Google Scholar
• Sadauskas E Wallin H Stoltenberg M et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol.4, 10 (2007).
   PubMedGoogle Scholar
• Singer JM Adlersberg L Sadek M . Long-term observation of intravenously injected colloidal gold in mice. J. Reticuloendothel. Soc.12 (6), 658–671 (1972).
   PubMedGoogle Scholar
• Melancon MP Lu W Yang Z et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol. Cancer Ther.7 (6), 1730–1739 (2008).
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N Cai Z Pignol J-P et al. Design and characterization of HER-2-targeted gold nanoparticles for enhanced x-radiation treatment of locally advanced breast cancer. Mol. Pharm.7 (6), 2194–2206 (2010).
   PubMedGoogle Scholar
• Kumar A Ma H Zhang X et al. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials33 (4), 1180–1189 (2012).
   PubMed Web of Science ®Google Scholar
• Meyers JD Cheng Y Broome AM et al. Peptide-targeted gold nanoparticles for photodynamic therapy of brain cancer. Part. Part. Syst. Charact.32 (4), 448–457 (2015).
   PubMed Web of Science ®Google Scholar
• Rathinaraj P Lee K Park S-Y Kang I-K . Targeted images of KB cells using folate-conjugated gold nanoparticles. Nanoscale Res. Lett.10, 5 (2015).
   PubMed Web of Science ®Google Scholar
• Chanda N Kattumuri V Shukla R et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc. Natl Acad. Sci. USA107 (19), 8760–8765 (2010).
   PubMed Web of Science ®Google Scholar
• Choi CHJ Alabi CA Webster P Davis ME . Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl Acad. Sci. USA107 (3), 1235–1240 (2010).
   PubMed Web of Science ®Google Scholar
• Pirollo KF Chang EH . Does a targeting ligand influence nanoparticle tumor localization or uptake?Trends Biotechnol.26 (10), 552–558 (2008).
   PubMed Web of Science ®Google Scholar
• Huang X Peng X Wang Y et al. A re-examination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano4 (10), 5887–5896 (2010).
   PubMed Web of Science ®Google Scholar
• Charan S Sanjiv K Singh N et al. Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation. Bioconjug. Chem.23 (11), 2173–2182 (2012).
   PubMed Web of Science ®Google Scholar
• Patra CR Bhattacharya R Mukhopadhyay D Mukherjee P . Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev.62 (3), 346–361 (2010).
   PubMed Web of Science ®Google Scholar
• Peiris PM Deb P Doolittle E et al. Vascular targeting of a gold nanoparticle to breast cancer metastasis. J. Pharm. Sci.104 (8), 2600–2610 (2015).
   PubMed Web of Science ®Google Scholar
• De Jong WH Hagens WI Krystek P Burger MC Sips AJ Geertsma RE . Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials29 (12), 1912–1919 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou C Long M Qin Y Sun X Zheng J . Luminescent gold nanoparticles with efficient renal clearance. Angewandte Chemie International Edition50 (14), 3168–3172 (2011).
   PubMed Web of Science ®Google Scholar
• Bertrand N Wu J Xu X Kamaly N Farokhzad OC . Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev.66, 2–25 (2014).
   PubMed Web of Science ®Google Scholar
• Bae YH Park K . Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Rel.153 (3), 198–205 (2011).
   PubMed Web of Science ®Google Scholar
• Arvizo RR Miranda OR Moyano DF et al. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One6 (9), e24374 (2011).
   PubMed Web of Science ®Google Scholar
• Hirn S Semmler-Behnke M Schleh C et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm. e.V77 (3), 407–416 (2011).
   PubMed Web of Science ®Google Scholar
• Liu Y Sun J Han J He Z . Long-circulating targeted nanoparticles for cancer therapy. Current Nanosci.6 (4), 347–354 (2010).
   Web of Science ®Google Scholar
• Moghimi SM Hunter AC Murray JC . Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev.53 (2), 283–318 (2001).
   PubMed Web of Science ®Google Scholar
• Jokerst JV Lobovkina T Zare RN Gambhir SS . Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.)6 (4), 715–728 (2011).
   PubMed Web of Science ®Google Scholar
• Blanco E Shen H Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotech.33 (9), 941–951 (2015).
   PubMed Web of Science ®Google Scholar
• Doane T Burda C . Nanoparticle mediated non-covalent drug delivery. Adv. Drug Deliv. Rev.65 (5), 607–621 (2013).
   PubMed Web of Science ®Google Scholar
• Albanese A Chan WCW . Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano5 (7), 5478–5489 (2011).
   PubMed Web of Science ®Google Scholar
• Walkey CD Olsen JB Guo H Emili A Chan WCW . Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc.134 (4), 2139–2147 (2012).
   PubMed Web of Science ®Google Scholar
• Dai Q Walkey C Chan WCW . Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angewandte Chemie53 (20), 5093–5096 (2014).
   Google Scholar
• Perrault SD Walkey C Jennings T Fischer HC Chan WCW . Mediating tumor targeting efficiency of nanoparticles through design. Nano Letters9 (5), 1909–1915 (2009).
   PubMed Web of Science ®Google Scholar
• Larson TA Joshi PP Sokolov K . Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano6 (10), 9182–9190 (2012).
   PubMed Web of Science ®Google Scholar
• Maus L Dick O Bading H Spatz JP Fiammengo R . Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. ACS Nano4 (11), 6617–6628 (2010).
   PubMed Web of Science ®Google Scholar
• Rodriguez PL Harada T Christian DA Pantano DA Tsai RK Discher DE . Minimal ‘self’ peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science (N.Y.)339 (6122), 971–975 (2013).
   PubMed Web of Science ®Google Scholar
• Röhme D . Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl Acad. Sci. USA78 (8), 5009–5013 (1981).
   PubMed Web of Science ®Google Scholar
• Kay MM . Mechanism of removal of senescent cells by human macrophages in situ. Proc. Natl Acad. Sci. USA72 (9), 3521–3525 (1975).
   PubMed Web of Science ®Google Scholar
• Hu C-MJ Zhang L Aryal S Cheung C Fang RH Zhang L . Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA108 (27), 10980–10985 (2011).
   PubMed Web of Science ®Google Scholar
• Parodi A Quattrocchi N Van De Ven AL et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat. Nano8 (1), 61–68 (2013).
   PubMed Web of Science ®Google Scholar
• Tenzer S Docter D Kuharev J et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nano8 (10), 772–781 (2013).
   PubMed Web of Science ®Google Scholar
• Ritz S Schöttler S Kotman N et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules16 (4), 1311–1321 (2015).
   PubMed Web of Science ®Google Scholar
• Schöttler S Becker G Winzen S et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat. Nano11 (4), 372–377 (2016).
   PubMed Web of Science ®Google Scholar
• Fleischer CC Payne CK . Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J. Phys. Chem. B.118 (49), 14017–14026 (2014).
   PubMed Web of Science ®Google Scholar
• Walkey CD Olsen JB Song F et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano8 (3), 2439–2455 (2014).
   PubMed Web of Science ®Google Scholar
• Geng Y Dalhaimer P Cai S et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nano2 (4), 249–255 (2007).
   PubMed Web of Science ®Google Scholar
• Wang J Bai R Yang R et al. Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration. Metallomics7 (3), 516–524 (2015).
   PubMed Web of Science ®Google Scholar
• Maltzahn GV Park J-H Agrawal A et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer res.69 (9), 3892–3900 (2009).
   PubMed Web of Science ®Google Scholar
• Wilhelm S Tavares AJ Dai Q et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater.1, 16014 (2016).
   Web of Science ®Google Scholar
• Nichols JW Bae YH . Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today7 (6), 606–618 (2012).
   PubMed Web of Science ®Google Scholar
• Li M Panagi Z Avgoustakis K Reineke J . Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int. J. Nanomed.7, 1345–1356 (2012).
   PubMed Web of Science ®Google Scholar
• Wang B He X Zhang Z Zhao Y Feng W . Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acct Chem. Res.46 (3), 761–769 (2012).
   PubMed Web of Science ®Google Scholar
• Brenner BM Bohrer MP Baylis C Deen WM . Determinants of glomerular permselectivity: insights derived from observations in vivo. Kidney Int.12 (4), 229–237 (1977).
   PubMed Web of Science ®Google Scholar
• Chou LYT Zagorovsky K Chan WCW . DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat. Nano9 (2), 148–155 (2014).
   PubMed Web of Science ®Google Scholar
• Soo Choi H Liu W Misra P et al. Renal clearance of quantum dots. Nat. Biotech.25 (10), 1165–1170 (2007).
   PubMed Web of Science ®Google Scholar
• Pérez-Campaña C Gómez-Vallejo V Puigivila M et al. Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. ACS Nano7 (4), 3498–3505 (2013).
   PubMed Web of Science ®Google Scholar
• Singh R Pantarotto D Lacerda L et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl Acad. Sci. USA103 (9), 3357–3362 (2006).
   PubMed Web of Science ®Google Scholar
• Haschek WM Rousseaux CG Wallig MA . Kidney and lower urinary tract. In : Fundamentals of Toxicologic Pathology (2nd Edition). Academic Press, San Diego, CA, USA, 261–318 (2010).
   Google Scholar
• Lipka J Semmler-Behnke M Sperling RA et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials31 (25), 6574–6581 (2010).
   PubMed Web of Science ®Google Scholar
• Liu T Choi H Zhou R Chen IW . RES blockade. A strategy for boosting efficiency of nanoparticle drug. Nano Today10 (1), 11–21 (2015).
   Web of Science ®Google Scholar
• Crofton R Diesselhoff-Den Dulk M Furth R . The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J. Exp. Med.148 (1), 1–17 (1978).
   PubMed Web of Science ®Google Scholar
• Sadauskas E Danscher G Stoltenberg M Vogel U Larsen A Wallin H . Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine5 (2), 162–169 (2009).
   PubMed Web of Science ®Google Scholar
• Tam JM Tam JO Murthy A et al. Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications. ACS Nano4 (4), 2178–2184 (2010).
   PubMed Web of Science ®Google Scholar